- Home
- IPW vs RFL Comparison
IPW vs RFL Comparison
Compare IPW & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- RFL
- Stock Information
- Founded
- IPW 2018
- RFL 2017
- Country
- IPW United States
- RFL United States
- Employees
- IPW N/A
- RFL N/A
- Industry
- IPW Catalog/Specialty Distribution
- RFL Real Estate
- Sector
- IPW Consumer Discretionary
- RFL Finance
- Exchange
- IPW Nasdaq
- RFL Nasdaq
- Market Cap
- IPW 48.0M
- RFL 48.4M
- IPO Year
- IPW 2021
- RFL N/A
- Fundamental
- Price
- IPW $2.02
- RFL $2.32
- Analyst Decision
- IPW Strong Buy
- RFL
- Analyst Count
- IPW 1
- RFL 0
- Target Price
- IPW $2.75
- RFL N/A
- AVG Volume (30 Days)
- IPW 685.6K
- RFL 65.0K
- Earning Date
- IPW 11-12-2024
- RFL 12-12-2024
- Dividend Yield
- IPW N/A
- RFL N/A
- EPS Growth
- IPW N/A
- RFL N/A
- EPS
- IPW N/A
- RFL N/A
- Revenue
- IPW $86,071,485.00
- RFL $540,000.00
- Revenue This Year
- IPW $8.31
- RFL N/A
- Revenue Next Year
- IPW $77.15
- RFL N/A
- P/E Ratio
- IPW N/A
- RFL N/A
- Revenue Growth
- IPW N/A
- RFL 92.86
- 52 Week Low
- IPW $0.40
- RFL $1.29
- 52 Week High
- IPW $3.65
- RFL $2.50
- Technical
- Relative Strength Index (RSI)
- IPW 60.57
- RFL 80.52
- Support Level
- IPW $1.48
- RFL $2.00
- Resistance Level
- IPW $2.36
- RFL $1.94
- Average True Range (ATR)
- IPW 0.25
- RFL 0.10
- MACD
- IPW -0.01
- RFL 0.03
- Stochastic Oscillator
- IPW 63.04
- RFL 77.78
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.